CHANELL CHARAPATA: Open Payments
NPI 1609284611 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 11 payments from 7 companies in 2025. Trend: 2023 $372 · 2024 $374 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $118 |
| Janssen Biotech, Inc. | 2 | $49 |
| Organon LLC | 3 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Incyte Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: DAXXIFY, TREMFYA, VTAMA, COSENTYX, Winlevi, OPZELURA, SKYRIZI.
Industry payments across CO — which companies pay providers there.
